- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01596998
Plasma Concentrations of Levobupivacaine With and Without Epinephrine in Transversus Abdominis Plane Blocks
Comparison of Plasma Concentrations of Levobupivacaine With and Without Epinephrine for Transversus Abdominis Plane Block Under Ultrasound.
Study Overview
Status
Conditions
Detailed Description
Use of TAP blocks, decreases use of opioids and reduces pain scores during the postoperative period after surgeries involving the anterior abdominal wall. However, the information regarding the sensitive range of the blockade and its duration is still limited. Since that the area of administration is an intermuscular plane, it is possible to infer a large area of absorption. Knowing plasma concentrations is essential to balance the usefulness of this technique with potential systemic toxicity associated with its use.
As an additional effect, clinically, the use of vasoconstrictors may prolong the duration of the blockade significantly, depending on the drug used and site of administration. To date, no studies evaluating the effect of the addition of vasoconstrictor both in the plasma concentrations achieved, and the quality, extent and duration of the TAP block.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Region Metropolitana
-
Santiago, Region Metropolitana, Chile
- Hospital Clinico Universidad Catolica
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy male volunteers
- ASA I-II
Exclusion Criteria:
- BMI > 30kg m-2
- Patients with allergy to study drugs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Levobupivacaine without epinephrine
|
The subjects were randomized to receive a unilateral TAP block.
This was realized using a sterile technique, guided by ultrasound.
Two operators with experience in ultrasound-guided regional blocks performed all procedures.
A high-resolution linear U.S. transducer (L38x/10-5 MHz, Sonosite M-Turbo ®, Bothell, WA) and a Stimuplex 100 mm needle, 20 gauge (B.
Braun Stimuplex, Melgusen, Germany) were used.
After obtaining a clear view of the blocking plane, between internal oblique and transverse muscles, 20 ml of levobupivacaine 0.25% were injected.
Standard anesthetic monitoring was used, including continuous electrocardiogram, non invasive blood pressure and peripheral oxygen saturation.
Later, under local anesthesia a permeable venous line and an arterial line were installed for blood sampling measures to determine local anesthetic plasma levels.
The extent of sensory block was measured by assessment of temperature, soft and hard touch using alcohol, cotton and pin prick respectively.
These measurements were made every 10 minutes during the first hour and every 30 minutes to complete 4 hours.
|
Experimental: Levobupivacaine with epinephrine
|
Standard anesthetic monitoring was used, including continuous electrocardiogram, non invasive blood pressure and peripheral oxygen saturation.
Later, under local anesthesia a permeable venous line and an arterial line were installed for blood sampling measures to determine local anesthetic plasma levels.
The subjects were randomized to receive a unilateral TAP block.
This was realized using a sterile technique, guided by ultrasound.
Two operators with experience in ultrasound-guided regional blocks performed all procedures.
A high-resolution linear U.S. transducer (L38x/10-5 MHz Sonosite M-Turbo®, Bothell, WA) and a Stimuplex 100 mm needle, 20 gauge (B.
Braun Stimuplex, Melgusen, Germany) were used.
After obtaining a clear view of the blocking plane, between internal oblique and transverse muscles, 20 ml of levobupivacaine 0.25% with 5 µg/mL epinephrine were injected.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Effect of the addition of vasoconstrictor in the plasma concentrations achieved
Time Frame: Since the beginning of the block up to 90 minutes after
|
Since the beginning of the block up to 90 minutes after
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Determine the mapping of sensory block in the abdominal wall after the completion of a U.S. guided TAP Block in healthy volunteers.
Time Frame: Since the beginning of the block up to 4 hours after
|
Since the beginning of the block up to 4 hours after
|
Collaborators and Investigators
Investigators
- Principal Investigator: Fernando R Altermatt, MD, Departamento de Anestesiología, Hospital Clínico Pontificia Universidad Católica de Chile
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Anesthetics, Local
- Bronchodilator Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Adrenergic beta-Agonists
- Sympathomimetics
- Vasoconstrictor Agents
- Mydriatics
- Levobupivacaine
- Epinephrine
- Racepinephrine
- Epinephryl borate
Other Study ID Numbers
- 11-026
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transversus Abdominis Plane Block
-
Yuzuncu Yıl UniversityCompletedTransversus Abdominis Plane BlockTurkey
-
Assiut UniversityCompleted
-
Herlev HospitalGlostrup University Hospital, CopenhagenCompleted
-
Damanhour Teaching HospitalCompletedTransversus Abdominis Plane (TAP) BlockEgypt
-
The Hospital for Sick ChildrenCompleted
-
The General Authority for Teaching Hospitals and...CompletedCesarean Section | Quadratus Lumborum Block | Transversus Abdominis Plane BlockEgypt
-
United Christian HospitalUnknownTransversus Abdominis Plane Block From Abdominal ApproachHong Kong
-
University Hospital, BordeauxCompletedAbdominoplasty | Transversus Abdominis Plane (TAP) BlockFrance
-
University Tunis El ManarCompletedCesarean Section | Anesthesia | Adverse Effect | Transversus Abdominis Plane Block
-
Chinese PLA General HospitalUnknownLearning Curve | Simulation Training | Transversus Abdominis Plane BlockChina
Clinical Trials on Levobupivacaine without epinephrine
-
Pontificia Universidad Catolica de ChileUnknownSurgery | Nerve Block | Anesthetic Toxicity | Anesthetics Complications | Bupivacaine OverdoseChile
-
Tel Aviv UniversitySheba Medical Center; Private practice, Dr. Malka AshkenaziUnknown
-
Pontificia Universidad Catolica de ChileUnknown
-
Research Institute of Ophthalmology, EgyptRecruitingPediatric Squint SurgeriesEgypt
-
University of PatrasCompletedPostoperative Pain | Morbid Obesity | Postoperative Bowel Function | Postoperative AmbulationGreece
-
University Hospital, AntwerpCompletedOther Peripheral Nerve Disease
-
Duzce UniversityCompletedPain, Postoperative | Cholecystectomy, LaparoscopicTurkey
-
Assiut UniversityCompletedPain, Postoperative | AnalgesiaEgypt
-
Balikesir UniversityCompleted
-
Assiut UniversityCompletedLevobupivacaine | Post-tonsillectomy AnalgesiaEgypt